Fingerprint
Dive into the research topics of 'Phase 1 study of Lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically